# SARS-CoV-2 Serological Antibody Testing for Disease Surveillance and Clinical Use

> **NIH NIH U01** · KAISER FOUNDATION RESEARCH INSTITUTE · 2022 · $194,620

## Abstract

We propose a two-year collaborative project to synchronize data harmonization efforts and analyses of  individual-level data in immunocompromised populations to assess effectiveness of vaccine boosters and  immune responses using data from 11 Serological Sciences Network (SeroNet) institutions. Our goal is to  inform public health guidelines on COVID-19 vaccine and boosters to reduce SARS-CoV-2 infection and  severe illness in these vulnerable populations.

## Key facts

- **NIH application ID:** 10706733
- **Project number:** 3U01CA260584-02S1
- **Recipient organization:** KAISER FOUNDATION RESEARCH INSTITUTE
- **Principal Investigator:** Jacek Skarbinski
- **Activity code:** U01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $194,620
- **Award type:** 3
- **Project period:** 2020-09-30 → 2025-03-24

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10706733

## Citation

> US National Institutes of Health, RePORTER application 10706733, SARS-CoV-2 Serological Antibody Testing for Disease Surveillance and Clinical Use (3U01CA260584-02S1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10706733. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*